glp-1-directed nmda receptor antagonism for obesity treatment Weight Reduction with GLP-1 Agonists and Paths Discontinuation While Maintaining Weight Loss glp-1-directed nmda receptor antagonism for

Recap Key Actions To maximize muscle preservation while losing weight with GLP-1 therapy, the core recommendations are: Strength Train Consistently: Engage in strength training exercises targeting all major muscle groups 2-3 times per week on non-consecutive days

Glucose pulls water with it

doi: 10.1093/eurheartj/ehae613

Cell Metab 33:833-844 e835 Zhu H, Zhang Y, Shi Z, Lu D, Li T, Ding Y, Ruan Y, Xu A (2016) The neuroprotection of liraglutide against ischaemia-induced apoptosis through the activation of the PI3K/AKT and MAPK pathways

Patient safety considerations : GLP-1 medications carry potential adverse effects including nausea, vomiting, diarrhoea, constipation, and rarely, pancreatitis or gallbladder disease